S&P 500 Healthcare Sector Stocks
The healthcare sector spans pharmaceuticals, biotechnology, medical devices, and health insurers. Healthcare stocks offer defensive characteristics with growth from innovation.
Updated Rebuilt every weekday after the closeAbout this data
Stocks
150
Total Market Cap
$6.90T
Advancing
126
Declining
20
Top Gainer
MRNA
+14.21%
Top Loser
CVS
-1.86%
Healthcare Stocks
Symbol | Name | Price | 1D | YTD | ||||
|---|---|---|---|---|---|---|---|---|
| LLY | Lilly (Eli) | $1.11T | -- | +0.83% | +2.48% | +5.01% | +9.73% | 70 |
| JNJ | Johnson & Johnson | $630.0B | -- | +1.93% | +2.13% | -1.84% | +26.33% | 38 |
| ABBV | AbbVie | $488.5B | -- | +1.49% | +5.82% | +8.42% | +21.00% | 94 |
| MRK | Merck & Co. | $359.6B | -- | +2.26% | +1.34% | +0.62% | +38.32% | 58 |
| UNH | UnitedHealth Group | $344.5B | -- | +2.25% | +1.87% | -2.31% | +14.90% | 44 |
| TMO | Thermo Fisher Scientific | $243.3B | -- | +0.93% | +1.54% | +9.09% | +13.56% | 91 |
| AMGN | Amgen | $223.9B | -- | +1.82% | +3.97% | +8.47% | +26.75% | 85 |
| GILD | Gilead Sciences | $187.4B | -- | +2.77% | +5.56% | +4.39% | +23.16% | 63 |
| ABT | Abbott Laboratories | $172.3B | -- | +1.13% | +1.80% | -3.64% | -20.50% | 21 |
| PFE | Pfizer | $161.2B | -- | +1.65% | +2.28% | +2.28% | +13.57% | 49 |
| DHR | Danaher Corporation | $154.6B | -- | +1.11% | +2.83% | +9.64% | -3.95% | 74 |
| ISRG | Intuitive Surgical | $149.8B | -- | +2.06% | +8.77% | +17.62% | -25.14% | 61 |
| VRTX | Vertex Pharmaceuticals | $129.5B | -- | +1.36% | +1.05% | -0.87% | +12.51% | 62 |
| BMY | Bristol Myers Squibb | $120.8B | -- | -0.77% | -1.29% | -7.26% | +9.60% | 19 |
| MDT | Medtronic | $113.3B | -- | +0.83% | +2.49% | -3.43% | -7.89% | 35 |
| CVS | CVS Health | $109.9B | -- | -1.86% | -0.61% | -9.58% | +8.57% | 40 |
| MCK | McKesson Corporation | $109.9B | -- | +0.92% | +3.71% | +6.58% | +14.45% | 67 |
| SYK | Stryker Corporation | $106.3B | -- | +0.13% | +0.66% | +2.71% | -21.09% | 8 |
| HCA | HCA Healthcare | $97.7B | -- | +1.37% | +5.72% | +7.09% | -3.38% | 38 |
| ELV | Elevance Health | $89.5B | -- | +2.93% | +6.46% | -0.92% | +17.73% | 90 |
| MRNA | Moderna | $89.3B | -- | +14.21% | +17.55% | +64.69% | +662.97% | -- |
| REGN | Regeneron Pharmaceuticals | $76.9B | -- | +0.94% | +1.66% | -5.89% | -3.28% | 30 |
| CI | Cigna | $74.6B | -- | +0.50% | +4.60% | +0.54% | +2.62% | 41 |
| BSX | Boston Scientific | $63.5B | -- | +1.64% | +0.47% | -0.86% | -55.19% | 10 |
| COR | Cencora | $63.0B | -- | +0.78% | +4.66% | +0.90% | -4.12% | 61 |
| CAH | Cardinal Health | $55.6B | -- | -0.58% | +3.69% | +0.66% | +15.61% | 52 |
| HUM | Humana | $51.8B | -- | +11.34% | +10.53% | +7.56% | +68.29% | 97 |
| BDX | Becton Dickinson | $50.6B | -- | +0.55% | +4.06% | +4.15% | +20.44% | 74 |
| EW | Edwards Lifesciences | $49.1B | -- | +1.15% | -0.50% | -1.80% | -0.05% | 48 |
| A | Agilent Technologies | $48.2B | -- | +1.41% | +1.91% | +19.16% | +25.33% | 92 |